SEC Form 3 · accession 0001562180-18-001357
PROGENICS PHARMACEUTICALS INC · PGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benedict Osorio
Officer — Senior Vice President, Quality
Period of report
Feb 20, 2018
Accepted (ET)
Mar 2, 2018 · 2:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000835887
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Progenics Pharmaceuticals, Inc. Common StockF1 | holding | — | — | — | 21,202 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Jointly owned with Robin A. Osorio (spouse).